Varenicline

Routes
Oral (PO)
Half-Life (t½)
PO: 24h
Formula
C13H13N3
Molecular Weight
211.27 g/mol
PubChem CID
5310966
Aliases
Chantix

Pharmacological Mechanism

Partial agonist at α4β2 nicotinic ACh receptor — reduces cigarette craving + withdrawal while blocking the reinforcing effect of smoked nicotine. Most efficacious smoking-cessation agent in head-to-head trials. Neuropsychiatric concerns (FDA black-box removed 2016 after EAGLES trial).

Half-Life & Elimination Curve (PO: 24h)

100%50%25%12.5%0%0h0×t½24h1×t½48h2×t½3d3×t½4d4×t½5d5×t½0×t½ (0h): 100% remaining (~1.89 µg/L)1×t½ (24h): 50% remaining (~0.945 µg/L)2×t½ (48h): 25% remaining (~0.473 µg/L)3×t½ (3d): 12.5% remaining (~0.236 µg/L)4×t½ (4d): 6.3% remaining (~0.118 µg/L)5×t½ (5d): 3.1% remaining (~0.0591 µg/L)
Plasma (PO)t½ Decay (24h)Effect Site (ke0)
  • 0×t½0h100% (1.89 µg/L)
  • 1×t½24h50% (0.945 µg/L)
  • 2×t½48h25% (0.473 µg/L)
  • 3×t½3d12.5% (0.236 µg/L)
  • 4×t½4d6.3% (0.118 µg/L)
  • 5×t½5d3.1% (0.0591 µg/L)
Elimination t½24h (PO)
Rate Constant (ke)0.0289 h⁻¹
Time to Peak (Tmax)4.75h
Est. Peak (Cmax)1.89 µg/L
Clearance (CL)12 L/h
97% Washout (5×t½)5d

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References